Pacira | PCRX - Actif À Court Terme





Actif À Court Terme Changement Date
Astellas Pharma JPY 1.49T 63.68B 2026-06
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
Cara Therapeutics USD 25.33M 6.21M 2026-03
Coherus Biosciences USD 133.79M 72.25M 2026-06
Heron Therapeutics USD 229.84M 861K 2026-06
Ironwood Pharmaceuticals USD 332.29M 58.11M 2026-03
J&J USD 56.35B 3.42B 2026-09
Ligand Pharmaceuticals USD 1.46B 591.7M 2026-06
Nektar Therapeutics USD 589.04M 322.77M 2026-03
Novo Nordisk DKK 208.7B 31.38B 2026-06
Omeros USD 69.65M 26.53M 2025-06
Pacira USD 615.21M 100.25M 2026-06
Perrigo USD 2.45B 260.7M 2026-06
Pfizer USD 41.36B 1.46B 2026-06
Supernus Pharmaceuticals USD 723.5M 8.08M 2026-06
Teva Pharmaceutical Industries USD 13.76B 50M 2026-06
Xeris Pharmaceuticals USD 274.76M 23.08M 2026-06
Zoetis USD 6.36B 118M 2026-06